U.S. Senators Sherrod Brown (D-OH) and Bob Casey (D-PA) are calling on the Food and Drug Administration to take action after multiple reports of illness and two deaths linked to recalled baby formula from Abbott Nutrition.

The senators sent a letter to FDA Commissioner, Robert Califf to demand information on the FDA's actions and its plans to investigate these reports in order to prevent more infants from becoming ill or dying.

Because of the recall, parents are currently facing shortages of baby formula, so the senators are also requesting information on the current status of the FDA's investigation, as well as the steps the agency is taking to ensure there is enough formula on the shelves despite the shortage.

Additionally, the senators are seeking information about the FDA's interactions with Abbott Nutrition before the recall and pressing the agency to explain the delay in their response following initial reports of illness.

"It is unacceptable that the FDA was made aware of complaints and positive cases related to the Abbott Nutrition facility months before Abbott finally issued a voluntary recall of potentially contaminated infant formula, yet failed to alert the public, immediately initiate an inspection, or demand Abbott issue an immediate recall of these infant formula products," the senators wrote.

Powered infant formula manufactured at Abbott Nutrition's facility in Michigan was recalled back in February of 2022 due to reports of possible bacterial contamination affecting Similac, Alimentum and EleCare powdered formulas.

To check if your powdered formula is affected by the recall, click here.